Cite
HARVARD Citation
Van Mater, D. et al. (2021). A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC‐042). Pediatric blood & cancer. 68 (4), p. n/a. [Online].